Dementia care isn't just about new drugs, said the author of a cost-effectiveness study comparing collaborative care, Leqembi ...
A new study finds THC, when combined with an anti-inflammatory drug, improved memory and reduced Alzheimer’s-related brain damage in mice, raising hope for future treatment.
While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
The firm provided updates alongside Q4 and full-year 2025 financial results, and reported $19.29 billion and $65.18 billion ...
Scientists say combining a low-dose of THC with a common anti-inflammatory drug improved cognition and reduced ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 1 ...
Axon Neuroscience’s active tau immunotherapy, AADvac1, has been selected as the first tau-targeted therapy to enter a ...
Dr. Maarten Dewilde, an associate professor at KU Leuven, sat down with Technology Networks to discuss molecular engineering ...
Learn how the brain’s replay system helps us consolidate memories — and what goes wrong when Alzheimer’s disease interferes ...
Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related ...
A new study suggests low doses of THC, the main psychoactive ingredient in cannabis, may protect memory and reduce brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results